NDC 71399-2829-01 - Dibucaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71399-2829
- Requested NDC
- 71399-2829-01
- Package NDCs from labels
- 71399-2829-1, 71399-2829-2, 71399-2829-01
- Manufacturer
- Akron Pharma Inc.
- Effective date
- 2025-01-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dibucaine Ointment | Akron Pharma Inc. | 2025-01-12 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 71399-2829-1 | 2023-02-28 | Dibucaine Ointment |
| 71399-2829-2 | 2023-02-28 | Dibucaine Ointment |
| 71399-2829-1 | 2023-01-30 | Dibucaine Ointment |
| 71399-2829-2 | 2023-01-30 | Dibucaine Ointment |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71399-2829-1 | Dibucaine | 28 g in 1 TUBE | OINTMENT | 28 | 6 | |
| 71399-2829-2 | Dibucaine | 56 g in 1 TUBE | OINTMENT | 56 | 6 | |
| 71399-2829-2 | Dibucaine | 1 in 1 PACKAGE | OINTMENT | 1 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71399-2829 | DIBUCAINE OINTMENT [AKRON PHARMA INC.] | 6 | Current NDC, Legacy NDC, 3 package rows | 20250114_60469e43-ab6f-46d3-a1df-00e58275f565.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71399-2829-1 | GM - Gram | 71399-2829 | 3f757800-4f65-4c65-be72-d7b496835bb6 | 1 | 2021-09-07 |
| 71399-2829-2 | GM - Gram | 71399-2829 | db3bb464-5bc6-4590-8d1c-c687e77a7b06 | 1 | 2021-12-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rectal Care Cream Revivol | LIDOCAINE 5% | Derma Care Research Labs | a1c75161-f84a-e996-e053-2a95a90ac0c5 | 2024-12-19 | Warnings | M015 |
| DCH Numbing Relief | LIDOCAINE 5% | Derma Care Research Labs, LLC | ffd70a31-7d0c-d2d0-e053-6394a90a8674 | 2024-12-19 | Warnings | M015 |
| DCH Hemorrhoidal | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0050701f-4393-3f01-e063-6394a90a4e0e | 2024-12-19 | Warnings | M015 |
| Moshe Numbing Hemorrhoidal | LIDOCAINE 5% | Derma Care Research Labs | fbd5b488-1921-e9b7-e053-6294a90aba70 | 2024-12-19 | Warnings | M015 |
| DCH Rapid Relief Hemorrhoidal | LIDOCAINE 5%, PHENYLEPHRINE HYDROCHLORIDE 0.25% | Derma Care Research Labs | 00eef84c-a72e-3343-e063-6294a90aa4d8 | 2024-12-19 | Warnings | M015 |
| Formula 2 Skin Care | LIDOCAINE 5% | Derma Care Research Labs | a05d5e07-ae4b-38cc-e053-2a95a90abced | 2024-12-19 | Warnings | M015 |
| Revivol Hemorrhoid and Fissure | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0140cf68-b6a0-4378-e063-6394a90afee8 | 2024-12-19 | Warnings | M015 |
| Hemorroidal Cooling gel | PHENYLEPHRINE, WITCH HAZEL | Trifecta Pharmaceuticals Usa Llc | 651c0143-384c-3649-e053-2991aa0a0f28 | 2024-12-18 | Warnings | M015 |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c50cc6ad-e8a0-47c1-e053-2a95a90a4de6 | 2024-12-18 | Warnings | M015 |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | fe18fa61-83f9-8bf9-e053-6294a90a7585 | 2024-12-18 | Warnings | M015 |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c59dcb2a-392b-670b-e053-2995a90a9682 | 2024-12-18 | Warnings | M015 |
| TheraCare Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Veridian Healthcare | fab95657-d257-e671-e053-6294a90a59e0 | 2024-12-18 | Warnings | M015 |
| TN Dickinsons Witch Hazel Hemorrhoidal Pads | WITCH HAZEL | Dickinson Brands Inc. | 1b50f4dc-c26a-431a-ae18-c43513871b39 | 2024-12-18 | Warnings | M015 |
| RECTICARE | LIDOCAINE | Ferndale Laboratories, Inc. | 49cb48cf-7a26-4d7a-887f-2e98261d269d | 2024-12-17 | Warnings | M015 |
| Recticare Advanced | LIDOCAINE AND MINERAL OIL AND PHENYLEPHRINE HCL AND WHITE PETROLATUM | Ferndale Laboratories, Inc. | 209212a7-7b6e-4b26-9f31-0eeb76f026bf | 2024-12-17 | Warnings | M015 |
| RECTICARE | LIDOCAINE AND GLYCERIN | Ferndale Laboratories, Inc. | 2b94136a-4975-2925-e054-00144ff88e88 | 2024-12-17 | Warnings | M015 |
| PRAX | PRAMOXINE HYDROCHLORIDE | Ferndale Laboratories, Inc. | 674f0d8b-3d50-42b1-8401-d2967bcdf5cf | 2024-12-17 | Warnings | M015 |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Rugby | a5b5e0a9-eee9-2a1e-e053-2a95a90a464e | 2024-12-17 | Warnings | M015 |
| Warrior Rectal Care | LIDOCAINE 4%, PHENYLEPHRINE HYDROCHLORIDE 0.25% | Derma Care Research Labs | fc10cbc3-fc1b-ae09-e053-6394a90ac8f3 | 2024-12-15 | Warnings | M015 |
| Tucks Multi-Care Relief Kit (Tucks Hemorrhoidal and Tucks Medicated Cooling 40 Count) | GLYCERIN, LIDOCAINE, AND WITCH HAZEL | Blistex Inc | a7cb6d78-3048-43b3-afe7-4d862fdcfd3f | 2024-12-13 | Warnings | M015 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.